Medifast
Satya Jonnalagadda serves as Editor-in-Chief of PATHWAYS, the quarterly newsletter for the Cardiovascular Wellness Dietetic Practice Group of the Academy of Nutrition and Dietetics since October 2021. Currently holding the position of Vice President for Scientific and Clinical Affairs at Medifast, Inc., Satya also contributes as an Adjunct Associate Professor in the Department of Food Science and Nutrition at the University of Minnesota since 2012. Past roles include Director of Global Nutrition Science & Innovation at Abbott Nutrition and Director of Global Nutrition Science at KERRY. Satya has experience as a managing editor for SCAN wellness and as Principal Scientist at General Mills, with earlier positions in clinical sciences at Novartis Medical Nutrition. Educational credentials feature multiple degrees in nutrition, including a PhD from Virginia Tech and an MBA from Augsburg University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Medifast
5 followers
Medifast (NYSE: MED) is the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers Lifelong Transformation, One Healthy Habit at a Time®. Based on nearly 40 years of experience, Medifast has redefined direct selling by combining the best aspects of the model. Its community of thousands of independent OPTAVIA Coaches teach Clients to develop holistic healthy habits through products and clinically proven plans, the Habits of Health® Transformational System and comprehensive support from a community of like-minded people. In 2019, Medifast expanded the OPTAVIA movement globally, beginning with the Asia-Pacific region. Medifast is traded on the New York Stock Exchange and was named to Fortune's 100 Fastest-Growing Companies list in 2019 and Forbes' 100 Most Trustworthy Companies in America list in 2016 and 2017. For more information, visit www.MedifastInc.com or www.OPTAVIA.com.